BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 21791540)

  • 1. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
    Maisel AS; Mueller C; Fitzgerald R; Brikhan R; Hiestand BC; Iqbal N; Clopton P; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Aug; 13(8):846-51. PubMed ID: 21791540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure.
    Breidthardt T; Socrates T; Drexler B; Noveanu M; Heinisch C; Arenja N; Klima T; Züsli C; Reichlin T; Potocki M; Twerenbold R; Steiger J; Mueller C
    Crit Care; 2012 Jan; 16(1):R2. PubMed ID: 22226205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
    BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
    Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge.
    Ito M; Doi K; Takahashi M; Koyama K; Myojo M; Hosoya Y; Kiyosue A; Ando J; Noiri E; Yahagi N; Hirata Y; Komuro I
    J Cardiol; 2016 Feb; 67(2):184-91. PubMed ID: 26228001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C
    Crit Care; 2014 Feb; 18(1):R39. PubMed ID: 24581340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections.
    Breidthardt T; Christ-Crain M; Stolz D; Bingisser R; Drexler B; Klima T; Balmelli C; Schuetz P; Haaf P; Schärer M; Tamm M; Müller B; Müller C
    Am J Med; 2012 Feb; 125(2):168-75. PubMed ID: 22269620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.
    Ronco C; Cruz D; Noland BW
    Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study.
    Macdonald S; Arendts G; Nagree Y; Xu XF
    BMC Cardiovasc Disord; 2012 Feb; 12():8. PubMed ID: 22340728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care B-type natriuretic peptide and neutrophil gelatinase-associated lipocalin measurements for acute resuscitation: a pilot study.
    Howell E; Sen S; Palmieri T; Godwin Z; Bockhold J; Greenhalgh D; Tran NK
    J Burn Care Res; 2015; 36(2):e26-33. PubMed ID: 25188271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
    Shrestha K; Shao Z; Singh D; Dupont M; Tang WH
    Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
    Aghel A; Shrestha K; Mullens W; Borowski A; Tang WH
    J Card Fail; 2010 Jan; 16(1):49-54. PubMed ID: 20123318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
    Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
    Maisel AS; Wettersten N; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müller GA; Birkhahn R; Clopton P; Taub P; Vilke GM; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT
    J Am Coll Cardiol; 2016 Sep; 68(13):1420-1431. PubMed ID: 27659464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M; Lourenço P; Dias C; Amorim M; Rema J; Leite AB; Guimarães JT; Almeida P; Bettencourt P
    Int J Cardiol; 2013 Apr; 165(1):51-5. PubMed ID: 21872946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.